Elize Massard da Fonseca

ORCID:

https://orcid.org/0000-0003-3847-3105


Formação:

  • Fundação Getulio Vargas

    | Pós-Doutorado | 2014 - 2016

  • Centro de Estudos da Metrópole/Centro Brasileiro de Análise e Planejamento

    | Pós-Doutorado | 2012 - 2013

  • University of Edinburgh

    Politica Social | Doutorado | 2007 - 2011

  • Fundação Oswaldo Cruz

    Saúde Pública | Doutorado | 2005 - 2008

  • Fundação Oswaldo Cruz

    Saúde Pública | Mestrado | 2004 - 2005

  • Fundação Oswaldo Cruz

    Saúde Pública | Especialização | 2003 - 2004

  • Pontifícia Universidade Católica do Rio de Janeiro

    Formação de Psicologo e Bacharelado em Psicologia | Graduação | 1997 - 2001
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(90.24% artigos com DOI)

Titulo DOI Ano
The Political Economy of Vaccines during the COVID-19 Pandemic 10.1215/03616878-10910797 2024
The politics and governance of drug production in public-private partnerships: Brazil s response to hepatitis C 10.1080/17441692.2024.2350654 2024
Institutions and the politics of agency in COVID-19 response: Federalism, executive power, and public health policy in Brazil, India, and the U.S. 10.1017/S0047279422000642 2024
Vaccine Technology Transfer in a Global Health Crisis: Actors, Capabilities, and Institutions 10.1016/j.respol.2023.104739 2023
Increasing compliance with international pandemic law: international relations and new global health agreements 10.1016/S0140-6736(23)01527-1 2023
Dependency, Capacity, and Agency: Austerity and Leadership Failures in Brazil’s Homegrown COVID-19 Vaccine Efforts 10.1007/s12116-023-09403-1 2023
Perspectives in the study of the political economy of COVID -19 vaccine regulation 10.1111/rego.12413 2022
Captura ou não captura? Perspectivas analíticas no estudo de políticas regulatórias 10.1590/0034-761220200453 2021
Social policy as an integral component of pandemic response: Learning from COVID-19 in Brazil, Germany, India and the United States 10.1080/17441692.2021.1916831 2021
The Politics of COVID-19 Vaccination in Middle-Income Countries: Lessons from Brazil 10.1016/j.socscimed.2021.114093 2021
Political Discourse, Denialism and Leadership Failure in Brazil?s Response to COVID-19 10.1080/17441692.2021.1945123 2021
O Índice de Capital Humano: Um desafio para o Brasil 10.1590/1413-81232020259.32832018 2020
State-Sponsored Activism: Bureaucrats and Social Movements in Democratic Brazil 10.1080/00220388.2020.1750160 2020
The comparative politics of COVID-19: The need to understand government responses 10.1080/17441692.2020.1783340 2020
Brazil?s Fight against Hepatitis C - Universalism, Local Production, and Patents 10.1056/NEJMp1812959 2019
Building effective collaboration between health systems and the life sciences industry 10.1080/09614524.2019.1632799 2019
Teaching Qualitative Research Methods in Political Science: Does One Size Fits All? 10.1080/15512169.2019.1656081 2019
How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health-industry complex in Brazil 10.1080/17441692.2017.1396354 2018
Evolution of HIV/AIDS response in Brazil: Policy innovations and challenges in the fourth decade of the epidemic 10.1002/hpm.2452 2018
Integrating Science, Technology and Health Policies in Brazil: Incremental Change and Public Health Professionals as Agents of Reform 10.1017/s0022216x18001050 2018
Promoting and Regulating Generic Medicines: Brazil in Comparative Perspective 2017
Implementing Intellectual Property of Pharmaceuticals in Middle-Income Countries: A Case Study of Patent Regulation in Brazil 10.1215/03616878-3523970 2016
Pharmaceutical Autonomy and Public Health in Latin America: State, Society, and Industry in Brazil’s AIDS Program, By M. Flynn 10.1080/00220388.2016.1196523 2016
Increasing Access to Oral Anticancer Medicines in Middle-Income Countries: A Case Study of Private Health Insurance Coverage in Brazil 10.1200/JGO.2015.001917 2016
Federalism, the Economic-Industrial Health Care Complex and High-Cost Pharmaceutical Assistance in Brazil 10.1590/1413-81232015204.00562014 2015
Relevance of variation in use of terminology to define generic pharmaceutical products 2015
Reforming pharmaceutical regulation: A case study of generic drugs in Brazil 10.1016/j.polsoc.2014.03.004 2014
AIDS advocacy and intellectual property regulation in Brazil: information and influence 10.7448/IAS.17.1.19396 2014
Governing decentralized health policy in Brazil (e-letter response to Rich and Gomez) 2013
Health Policy as Industrial Policy: Brazil in Comparative Perspective 10.1177/0032329213507552 2013
Allocation of authority in European health policy 10.1016/j.socscimed.2012.05.041 2012
Comparing the US and Brazilian policy responses to the HIV/AIDS epidemic (e-letter) 2011
Behavior and major barriers faced by non-injectable drug users with HBV/HCV seeking treatment for hepatitis and drug addiction in Rio de Janeiro, Brazil 10.1590/s1413-81232011001300026 2011
AIDS Treatment In Brazil: Impacts And Challenges 10.1377/hlthaff.28.4.1103 2009
Changing global essential medicines norms to improve access to AIDS treatment: Lessons from Brazil 10.1080/17441690802684067 2009
Mobilizing Bias in Europe: Lobbies, Democracy and EU Health Policy-Making 10.1177/1465116508093491 2008
Descentralização, AIDS e redução de danos: a implementação de políticas públicas no Rio de Janeiro, Brasil 10.1590/s0102-311x2007000900021 2007
Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment 10.1371/journal.pmed.0040305 2007
Syringe exchange programs in Brazil: preliminary assessment of 45 programs 10.1590/s0102-311x2006000400015 2006
Supporting Adherence to Highly Active Antiretroviral Therapy and Protected Sex Among People Living with HIV/AIDS: The Role of Patient-Provider Communication in Rio De Janeiro, Brazil 10.1089/apc.2006.20.637 2006
Controlling Illegal Drugs: A Comparative Study 10.1016/j.drugpo.2004.10.001 2005
Eventos:
Nenhum evento cadastrado
Publicações:
Minha Rede: